The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern US

被引:4
|
作者
Van Gerwen, Olivia T. [1 ]
Yigit, Ibrahim [2 ]
Crockett, Kaylee B. [3 ]
Turan, Bulent [4 ,5 ]
机构
[1] Univ Alabama Birmingham, Div Infect Dis, 703 19th St South,ZRB 218A, Birmingham, AL 35233 USA
[2] TED Univ, Fac Arts & Sci, Dept Psychol, Ankara, Turkey
[3] Univ Alabama Birmingham, Dept Family & Community Med, Birmingham, AL USA
[4] Koc Univ, Coll Social Sci & Humanities, Dept Psychol, Istanbul, Turkey
[5] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
HIV pre-exposure prophylaxis; Adherence; Stigma; PrEP; TENOFOVIR DISOPROXIL FUMARATE; INTERNALIZED STIGMA; PREVENTION; MECHANISMS; INFECTION; EFFICACY; PEOPLE; SCALE; RISK; PREP;
D O I
10.1007/s10461-022-03883-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures of PrEP-related stigma dimensions and PrEP adherence. We administered them to current PrEP users. We hypothesized that PrEP-related stigma would negatively impact PrEP adherence. Questionnaire measures were developed using data from previous qualitative work and existing validated HIV-related stigma measures. The resultant survey was administered to current PrEP users from two Birmingham, Alabama PrEP clinics. Plasma tenofovir disoproxil fumarate levels were collected to measure PrEP adherence. Exploratory factor analyses were performed to determine the factor structure of each PrEP-related stigma dimension (internalized, perceived, experienced, anticipated, disclosure concerns). Separate binary logistic (or linear) regressions were performed to assess associations between PrEP-related stigma dimensions and adherence (treatment adherence self-efficacy, self-reported adherence, and plasma tenofovir levels), adjusting for education, race, and time on PrEP. In 2018, 100 participants completed the survey, with 91 identifying as male and 66 as white. Only internalized stigma was associated with lower self-reported PrEP adherence. Exploratory mediation analyses suggested that the association between all stigma dimensions and self-reported PrEP adherence is mediated by PrEP adherence self-efficacy. No associations were found between any PrEP-related stigma measures and plasma tenofovir levels. Internalized PrEP stigma may reduce PrEP adherence, possibly by reducing PrEP adherence self-efficacy among experienced PrEP users. Further investigation of how stigma dimensions affect PrEP adherence in populations at risk for HIV may shed light on drivers of PrEP underutilization.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [21] HIV pre-exposure prophylaxis in women
    Haberl A.
    MMW - Fortschritte der Medizin, 2017, 159 (Suppl 2) : 42 - 44
  • [22] Updates in pre-exposure prophylaxis for HIV
    Mushtaq, Ammara
    Kazi, Farooq
    LANCET INFECTIOUS DISEASES, 2022, 22 (03): : 320 - 320
  • [23] Pre-exposure prophylaxis against HIV
    不详
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2020, 98 (02) : 82 - 82
  • [24] HIV pre-exposure prophylaxis for women
    Sheth, Anandi N.
    Rolle, Charlotte P.
    Gandhi, Monica
    JOURNAL OF VIRUS ERADICATION, 2016, 2 (03) : 149 - 155
  • [25] PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION
    Cremin, I.
    Hallett, T.
    Dybul, M.
    Piot, P.
    Garnett, G.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A36 - A36
  • [26] Predictors of syphilis infection among HIV pre-exposure prophylaxis users
    Tran, Thanh Nguyen Ai
    Thanh, Vu-Tri
    Nguyen, Vu Hoang Anh
    Nguyen-Thi, My-Tien
    Luu-Thi, Huyen-Trang
    Ly, Thanh-Thao
    Phan, Yen Thi Hoai
    MEDICAL JOURNAL OF INDONESIA, 2025, 34 (01) : 63 - 67
  • [27] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
    Stein, Michael
    Thurmond, Portia
    Bailey, Genie
    AIDS AND BEHAVIOR, 2014, 18 (09) : 1694 - 1700
  • [28] Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care
    Kenison, Tiffany Cho
    Badenhop, Brittan
    Safo, Stella
    AIDS PATIENT CARE AND STDS, 2020, 34 (06) : 251 - 258
  • [29] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
    Michael Stein
    Portia Thurmond
    Genie Bailey
    AIDS and Behavior, 2014, 18 : 1694 - 1700
  • [30] Users' expectations of the new pre-exposure prophylaxis for the HIV modalities
    de Jesus, Monica Lima
    Vargas, Maricelly Gomez
    Iniguez-Rueda, Lupicinio
    Fernandez-Gonzalez, Emmanuelle
    da Silva, Luis Augusto Vasconcelos
    Cabrera, Jose Miguel
    Perez, Felix
    Saz, Jorge
    CIENCIA & SAUDE COLETIVA, 2024, 29 (06):